Sanjeev Kothare
Neurology with Special Qualifications in Child Neurology · New Hyde Park, NYNPI 1710932884
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $37,445 of the $53,456 with a category attached, or 70.0%. 21 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 27.7% of the total. Among neurology with special qualifications in child neurology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $453.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$15K
- Eisai Inc.$13K
- UCB, Inc.$6K
- Zogenix Inc.$6K
- UCB SA$6K
- Acadia Pharmaceuticals Inc$2K
- plus $5K from 15 others
Across 11 payments — averaging $23,377 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Greenwich Biosciences, Inc.$114K
- UCB SA$61K
- Jazz Pharmaceuticals Inc.$57K
- Neuropace, Inc.$15K
- Eisai Inc.$10K
What the payments were for
- Consulting fees$37,44570%
- Speaking & faculty fees$4,5008%
- Travel & lodging$5,51310%
- Food & beverage$5,68411%
- Education$3141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 27 | $14,797 |
| Eisai Inc. | 25 | $13,138 |
| UCB, Inc. | 23 | $6,241 |
| Zogenix Inc. | 4 | $5,900 |
| UCB SA | 2 | $5,864 |
| Acadia Pharmaceuticals Inc | 4 | $2,459 |
| Neuropace, Inc. | 8 | $1,916 |
| Livanova USA, Inc. | 4 | $1,007 |
| Vertex | 2 | $558 |
| ZOLL Medical Corporation | 2 | $490 |
| Greenwich Biosciences, Inc. | 2 | $228 |
| Sunovion Pharmaceuticals Inc. | 2 | $219 |
| SK Life Science, Inc. | 3 | $184 |
| Immedica Pharma US, Inc. | 1 | $118 |
| Biocodex, Inc. | 2 | $104 |
| Zimmer Biomet | 1 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $46 |
| Harmony Biosciences LLC | 1 | $46 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $44 |
| Axsome Therapeutics, Inc. | 1 | $38 |
| Travere Therapeutics, Inc. | 2 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fintepla$16,830
- Banzel$10,001
- XYWAV$9,504
- Epidiolex$4,013
- DAYBUE$2,400
- Fycompa$1,920
- RNS System$1,588
- VNS Therapy$738
- Briviact$270
- VNS - Sentiva$250
- RNS Neurostimulator Kit$178
- ZTALMY$118
How this compares
$53,456 in reported general payments places this provider in the 95th percentile of 161 neurology with special qualifications in child neurology providers in New York.
See all neurology with special qualifications in child neurology providers in New York →
Other neurology with special qualifications in child neurology in New Hyde Park
- Rami GrossmannNew Hyde Park$10K
- Nancy XiaNew Hyde Park$2K
- Claudia ChiribogaNew York$220K
- Eric SegalN White Plains$133K
- Kaleb YohayNew York$125K
- Heather LauNew York$103K
- Louis ManganasEast Setauket$86K
- Darryl DevivoNew York$67K
- Mary Lynn ChuNew York$66K
- Jonathan MinkRochester$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.